Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked ...

Seven years after the activation of the prostate biopsy service using Fusion technology, one of the most advanced innovations ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U ...

On 16 January 2026, Telix Pharmaceuticals announced that the first U.S. patient had been dosed in BiPASS, a Phase 3 trial ...

A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using ...

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.

Full-body MRI scans are gaining popularity, but doctors warn their benefits may not outweigh the risks for healthy, symptom-free individuals. While MRIs can detect certain cancers and abnormalities, ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...

Solomon Owusu, has hinted at plans to report a hospital to the United States Embassy over a disputed medical document.

What began as a late-night medical emergency for Alfred Ogene has turned into weeks of pain, confusion and lasting injury, ...

By recognizing patterns in test results, AI can identify patients at risk of cancer, diabetes complications, heart disease ...